Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

A nurse prepares a dose of PCV13 vaccine, Central African Republic. Photograph by Sandra Smiley
Press release
Press release |
19 September 2016
Vaccines

MSF response to GSK announcement to reduce pneumonia vaccine price for humanitarian organisations

3 min
MSF conducted immunization efforts for refugee children in Greece aged from 6 weeks to 15 years against six childhood diseases: measles, tetanus, pertussis, influenza, polio, hepatitis B and certain forms of pneumonia. Photograph by Pierre-Yves Bernard
Press release
Press release |
14 September 2016
Research and development

MSF response to report from UN Secretary-General’s High-Level Panel on Access to Medicines

3 min
A nurse dispensing TB medication inside Colony 3 TB prison. Photograph by Aleksandr Glyadyelov/MSF
Press release
Press release |
14 September 2016
Research and development

As UN General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs

4 min
Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape, South Africa.. Photograph by Sydelle Willow Smith
Press release
Press release |
02 September 2016
Intellectual property and trade
G20

MSF statement on G20 meeting in Hangzhou, China, 4-5 September 2016

3 min
Medecins Sans Frontieres (MSF) staff stock 17.000 icepacks in cooler containers for use in the massive Yellow Fever vaccination campaign in DRC Photograph by Dieter Telemans

Medecins Sans Frontieres (MSF) staff stock 17.000 icepacks in cooler containers for use in the massive Yellow Fever vaccination campaign in DRC.

Press release
Press release |
16 August 2016
Vaccines
Democratic Republic of the Congo

MSF mobilizes hundreds of workers for massive yellow fever vaccination in Kinshasa

Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines during the 6th round of negotiations. 3rd December 2014 Photograph by Siddharth Singh
Press release
Press release |
12 August 2016
Intellectual property and trade
India

RCEP agreement threatens to trade away health of millions of people globally

4 min
Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi Photograph by Siddharth Singh
Press release
Press release |
04 August 2016
Intellectual property and trade
IndiaASEAN

MSF statement on RCEP Ministerial meeting in Laos

MSF launched a vaccination campaign against measles in an attempt to control the epidemic that was declared by the government of Guinea on 14 January 2014. Photograph by Ikram N'gadi
Press release
Press release |
28 July 2016
Intellectual property and trade
India

MSF calls for affordable pneumonia vaccines ahead of Pfizer’s patent hearing in India

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury